| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | C |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | C |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | B |
| 12. CI | A |
| 13. No of Results | C |
| 14. Concentrations | B |
| 15. Total Score | C2,7,8,10,13 |
| Comment | Diseased subjects. Not included in meta analysys |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Prostate specific antigen (PSA) |
| Unit | ug / L |
| Overall Analytical Principle Method | Immunoassay; Not specified |
| Number of Subjects | 5 |
| Number of Subjects included in BV estimation | 5 |
| Ethinicity | Unknown |
| Age Mean / Median | |
| Age Min | |
| Age Max | |
| Age SD | |
| Number of Males | 5 |
| Number of Females | 0 |
| State of Well Being |
Non-healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 4 |
| Study Duration Units | Day |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 2 |
| Interval Units | Day |
| Sampling Times | Start Time:
07:00
End Time: 15:00 |
| Number of Samples | 8 |
| Average Number of Samples Used for BV Estimation | 8.0 |
| Average Number of Replicates | 8.0 |
| Estimates of CVi | 14.0 |
| Calculated Confidence Intervals of CVi | Lower: 11.32, Upper: 18.30 |
| Estimates of CVg | |
| Calculated Confidence Intervals of CVg | Lower: 0.00, Upper: |
| Analytical CV | 4.2 |
| Calculated Confidence Intervals of Analytical CV | Lower: 3.88, Upper: 4.58 |
| Measurand Mean | |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |